ChemMedChem
10.1002/cmdc.201800325
FULL PAPER
nonspecific binding (determined by heat denaturation, n = 3). For statistical
comparisons, data were examined by means of a t-test (two sided, α =
[21] A. Ring, B. Oddvar Strom, S. R. Turner, C. M. Timperley, M. Bird, A. C.
Green, J. E. Chad, F. Worek, J. E. H. Tattersall, PLoS ONE 10(8):
e0135811.
0.05). If not stated otherwise, results are given as means ± SEM.
[22] C. M. Timperley, M. Bird, C. Green, M. E. Price, J. E. Chad, S. R. Turner,
J. E. H. Tattersall, MedChemCommun. 2012, 3, 352–356.
Validation of the LC-ESI-MS/MS quantification method: In accordance
with the FDA’s guidance for bioanalytical method validation selectivity,
lower limit of quantification (LLOQ), linearity, precision, and accuracy were
investigated exactly in the same way as described for marker quantification
[
23] T. Wein, G. Höfner, S. Rappenglück, S. Sichler, K. V. Niessen, T. Seeger,
F. Worek, H. Thiermann, K. T. Wanner, Toxicol. Lett. 2017, in press.
–1
[24] S. Sichler, G. Höfner, S. Rappenglück, T. Wein, K. V. Niessen, T. Seeger,
F. Worek, H. Thiermann, F. F. Paintner, K. T. Wanner, Toxicol. Lett. 2017,
in binding samples resulting from incubation in presence of 1 mmol L
.[24]
CaCl
2
[
25] N. S. Millar, Biochem. Soc. Trans. 2003, 31, 869–874.
[26] M. Navedo, M. Nieves, L. Rojas, J. A. Lasalde-Dominicci, Biochemistry
004, 43 (1), 78–84.
Supporting Information
2
Synthetic procedures and analytical characterization of all compounds as
well as details to the improved MS Binding Assay protocol and validation
data can be found within the supporting information.
[
27] T. W. Bell, L. Y. Hu, S. V. Patel, J. Org. Chem. 1987, 52 (17), 3847–3850.
28] E. R. Bowman, H. Jr. McKennis, B. R. Martin, Synth. Commun. 1982, 12
[
(11), 871–879.
[29] C. H. Leung, A. R. Chianese, B. R. Garrett, C. S. Letko, R. H. Crabtree,
Inorg. Synth. 2010, 35, 84–87.
[30] S. Rappenglück, K. V. Niessen, T. Seeger, F. Worek, H. Thiermann, K.
T. Wanner, Synthesis 2017, 49 (17), 4055–4064.
Acknowledgements
[
31] N. Yoshikai, E. Nakamura, Chem. Rev. 2012, 112 (4), 2339–2372.
32] W. Henze, A. Vyater, N. Krause, R. M. Gschwind, J. Am. Chem. Soc.
This study was funded by the German Ministry of Defense
[
(
E/U2AD/CF514/DF561).
2005, 127 (49), 17335–17342.
[33]
J. Epsztajn, A. Bieniek, J. Chem. Soc., Perkin Trans. 1 1985, (2), 213–
Keywords: Resensitizer • MS Binding Assay • Bispyridinium •
219.
[
34] K. Musilek, M. Komloova, V. Zavadova, O. Holas, M. Hrabinova, M.
Pohanka, V. Dohnal, F. Nachon, M. Dolezal, K. Kuca, Y.-S. Jung, Bioorg.
Med. Chem. 2010, 20 (5), 1763–1766.
Drug design • Nitrogen heterocycles
[1]
D. Gunnell, M. Eddleston, M. R. Phillips, F. Konradsen, BMC Public
Health 2007, 7, 357–372.
[
35] K. Musilek, J. Roder, M. Komloova, O. Holas, M. Hrabinova, M. Pohanka,
V. Dohnal, V. Opletalova, K. Kuca, Y.-S. Jung, Bioorg. Med. Chem. 2011,
[2]
[3]
[4]
E. Dolgin, Nat. Med. 2013, 19 (10), 1194–1195.
J. Newmark, Neurologist 2007, 13 (1), 20–32.
21 (1), 150–154.
[
36] C. M. Timperley, M. Bird, S. C. Heard, S. Notman, R. W. Read, J. E. H.
Tattersall, S. R. Turner, J. Fluor. Chem. 2005, 126 (8), 1160–1165.
37] K. V. Niessen, T. Seeger, S. Rappenglück, T. Wein, G. Höfner, K. T.
Wanner, H. Thiermann, F. Worek, Toxicol. Lett. 2017, in press.
R. D. Sheridan, A. P. Smith, S. R. Turner, J. E. H. Tattersall, J. R. Soc.
Med. 2005, 98, 114–115.
[
[5]
R. Giniatullin, A. Nistri, J. L. Yakel, Trends Neurosci. 2005, 28 (7), 371–
378.
[
6]
7]
R. L. Papke, Biochem. Pharmacol. 2014, 89 (1), 1–11.
[
38] W. Cocker, N. W. A. Geraghty, T. B. H. McMurry, P. V. R. Shannon, J.
Chem. Soc., Perkin Trans. 1 1984, (10), 2245–2254.
[
H. Thiermann, T. Seeger, S. Gonder, N. Herkert, B. Antkowiak, T. Zilker,
F. Eyer, F. Worek, Chem. Biol. Interact. 2010, 187 (1-3), 265–269.
F. Worek, N. Aurbek, M. Koller, C. Becker, P. Eyer, H. Thiermann,
Biochem. Pharmacol. 2007, 73, 1807–1817.
[
39] United States Food and Drug Administration (FDA) 2001.
[
[
[
[
[
[
8]
(accessed 10.08.2017).
9]
F. Worek, H. Thiermann, L. Szinicz, P. Eyer, Biochem. Pharmacol. 2004,
[
[
[
40] D. D. Perrin, W. L. F. Armarego, Purification of Laboratory Chemicals,
6
8, 2237–2248.
10] F. Worek, H. Thiermann, T. Wille, Chem. Biol. Interact. 2016, 259, 93–
8.
Pergamon, New York, 1988.
41] M. Cushman, G. I. Georg, U. Holzgrabe, S. Wang, J. Med. Chem. 2016,
9
57 (22), 9219.
11] K. V. Niessen, S. Muschik, F. Langguth, S. Rappenglück, T. Seeger, H.
Thiermann, F. Worek, Toxicol. Lett. 2016, 247, 1–10.
42] G. F. Pauli, S.-N. Chen, C. Simmler, D. C. Lankin, T. Gödecke, B. U. Jaki,
J. B. Friesen, J. B. McAlpine, J. G. Napolitano, J. Med. Chem. 2014, 57,
12] D. K. Williams, J. Wang, R. L. Papke, Biochem. Pharmacol. 2011, 82 (8),
9
220−9231.
43] M. J Corr, K. F. Gibson, A. R. Kennedy, J. A. Murphy, J. Am. Chem. Soc.
009, 131 (26), 9174–9175.
915–930.
[
13] K. V. Niessen, T. Seeger, J. E. H. Tattersall, C. M. Timperley, M. Bird, C.
2
Green, H. Thiermann, F. Worek, Chem. Biol. Interact. 2013, 206, 545–
[
44] E. Lindner, G. Von Au, H. J Eberle, Chem. Ber. 1981, 114 (2), 810–813.
45] P. K. Smith, R. I. Krohn, G. T. Hermanson, A. K. Mallia, F. H. Gartner, M.
D. Provenzano, E. K. Fujimoto, N. M. Goeke, B. J. Olson, D. C. Klenk,
Anal. Biochem. 1985, 150 (1), 76–85.
554.
[
[
14] J. E. H. Tattersall, Br. J. Pharmacol, 1993, 108, 1006–1015.
15] S. R. Turner, J. E. Chad, M. Price, C. M. Timperley, M. Bird, A. C. Green,
J. E. H. Tattersall, Toxicol. Lett. 2011, 206, 105–111.
[
[16] T. Seeger, M. Eichhorn, M. Lindner, K. V. Niessen, J. E. H. Tattersall, C.
M. Timperley, M. Bird, A. C. Green, H. Thiermann, F. Worek, Toxicology
2
012, 294, 80–84.
17] C. Scheffel, K. V. Niessen, S. Rappenglück, K. T. Wanner, H. Thiermann,
F. Worek, T. Seeger, Toxicol. Lett. 2017 in press
[
[
18] K. V. Niessen, J. E. H. Tattersall, C. M. Timperley, M. Bird, C. Green, T.
Seeger, H. Thiermann, F. Worek, Toxicol. Lett. 2011, 206, 100–104.
19] M. E. Price, C. J. Docx, H. Rice, S. J. Fairhall, S. J. C. Poole, M. Bird, L.
Whiley, D. P. Flint, A. C. Green, C. M. Timperley, J. E. H. Tattersall,
Toxicol. Lett. 2016, 244, 154–160.
[
[20] K. Schoene, J. Steinhanses, H. Oldiges, Biochem. Pharmacol. 1976, 25,
1955–1958.
1
1
This article is protected by copyright. All rights reserved.